Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Assessing RET/PTC in thyroid nodule fine-needle aspirates: the FISH point of view.

Caria P, Dettori T, Frau DV, Borghero A, Cappai A, Riola A, Lai ML, Boi F, Calò P, Nicolosi A, Mariotti S, Vanni R.

Endocr Relat Cancer. 2013 Jun 27;20(4):527-36. doi: 10.1530/ERC-13-0157. Print 2013 Aug.

2.

Optimizing detection of RET and PPARg rearrangements in thyroid neoplastic cells using a home-brew tetracolor probe.

Caria P, Frau DV, Dettori T, Boi F, Lai ML, Mariotti S, Vanni R.

Cancer Cytopathol. 2014 May;122(5):377-85. doi: 10.1002/cncy.21397. Epub 2014 Feb 7.

3.

Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application.

Guerra A, Sapio MR, Marotta V, Campanile E, Moretti MI, Deandrea M, Motta M, Limone PP, Fenzi G, Rossi G, Vitale M.

Endocr J. 2011;58(1):31-8. Epub 2010 Dec 14.

4.

Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings.

Sapio MR, Posca D, Raggioli A, Guerra A, Marotta V, Deandrea M, Motta M, Limone PP, Troncone G, Caleo A, Rossi G, Fenzi G, Vitale M.

Clin Endocrinol (Oxf). 2007 May;66(5):678-83. Epub 2007 Mar 23.

PMID:
17381488
5.

Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules.

Musholt TJ, Fottner C, Weber MM, Eichhorn W, Pohlenz J, Musholt PB, Springer E, Schad A.

World J Surg. 2010 Nov;34(11):2595-603. doi: 10.1007/s00268-010-0729-4.

PMID:
20652698
6.

RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint.

Marotta V, Guerra A, Sapio MR, Vitale M.

Eur J Endocrinol. 2011 Oct;165(4):499-507. doi: 10.1530/EJE-11-0499. Epub 2011 Jul 12. Review.

7.

Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement.

Pizzolanti G, Russo L, Richiusa P, Bronte V, Nuara RB, Rodolico V, Amato MC, Smeraldi L, Sisto PS, Nucera M, Bommarito A, Citarrella R, Lo Coco R, Cabibi D, Lo Coco A, Frasca F, Gulotta G, Latteri MA, Modica G, Galluzzo A, Giordano C.

Thyroid. 2007 Nov;17(11):1109-15.

PMID:
17727338
8.

Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements.

Colato C, Vicentini C, Cantara S, Pedron S, Brazzarola P, Marchetti I, Di Coscio G, Chilosi M, Brunelli M, Pacini F, Ferdeghini M.

Eur J Endocrinol. 2015 May;172(5):571-82. doi: 10.1530/EJE-14-0930. Epub 2015 Feb 19.

9.

Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population.

Liu S, Gao A, Zhang B, Zhang Z, Zhao Y, Chen P, Ji M, Hou P, Shi B.

Exp Mol Pathol. 2014 Oct;97(2):292-7. doi: 10.1016/j.yexmp.2014.08.005. Epub 2014 Aug 8.

PMID:
25111330
10.

[Diagnostic value of BRAFV600E and RET/PTC oncogenes in thyroid nodule aspirates].

Guerra A, Carrano M, Angrisani E, Vitale M.

Recenti Prog Med. 2013 Jul-Aug;104(7-8):415-9. doi: 10.1701/1315.14588. Italian.

PMID:
24042420
11.

Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules.

Eszlinger M, Krogdahl A, Münz S, Rehfeld C, Precht Jensen EM, Ferraz C, Bösenberg E, Drieschner N, Scholz M, Hegedüs L, Paschke R.

Thyroid. 2014 Feb;24(2):305-13. doi: 10.1089/thy.2013.0278. Epub 2013 Oct 29.

PMID:
23837487
12.

Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma.

Salvatore G, Giannini R, Faviana P, Caleo A, Migliaccio I, Fagin JA, Nikiforov YE, Troncone G, Palombini L, Basolo F, Santoro M.

J Clin Endocrinol Metab. 2004 Oct;89(10):5175-80.

PMID:
15472223
13.

A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.

Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, Pinchera A, Bevilacqua G.

Thyroid. 2009 Aug;19(8):837-42. doi: 10.1089/thy.2009.0074.

PMID:
19534623
14.

Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.

Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P.

Cytopathology. 2014 Jun;25(3):146-54. doi: 10.1111/cyt.12125. Epub 2014 Jan 12.

PMID:
24417615
15.

Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears.

Ferraz C, Rehfeld C, Krogdahl A, Precht Jensen EM, Bösenberg E, Narz F, Hegedüs L, Paschke R, Eszlinger M.

Thyroid. 2012 Oct;22(10):1025-30. doi: 10.1089/thy.2011.0391.

16.

Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".

Jara SM, Bhatnagar R, Guan H, Gocke CD, Ali SZ, Tufano RP.

Head Neck. 2015 Dec;37(12):1788-93. doi: 10.1002/hed.23829. Epub 2014 Sep 25.

PMID:
24989827
17.
18.

Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer.

Cheung CC, Carydis B, Ezzat S, Bedard YC, Asa SL.

J Clin Endocrinol Metab. 2001 May;86(5):2187-90.

PMID:
11344225
19.

Preoperative cytology with molecular analysis to help guide surgery for pediatric thyroid nodules.

Buryk MA, Monaco SE, Witchel SF, Mehta DK, Gurtunca N, Nikiforov YE, Simons JP.

Int J Pediatr Otorhinolaryngol. 2013 Oct;77(10):1697-700. doi: 10.1016/j.ijporl.2013.07.029. Epub 2013 Aug 9.

PMID:
23993207
20.

[BRAF V600E mutation in papillary thyroid carcinoma: prevalence and detection in fine needle aspiration specimens].

Dujardin F, Pagès JC, Collin C, de Calan L, Lecomte P, Guyétant S.

Ann Pathol. 2010 Aug;30(4):252-62. doi: 10.1016/j.annpat.2010.05.011. Epub 2010 Jul 29. French.

PMID:
20837233

Supplemental Content

Support Center